Philip Carpino
Philip Carpino is a highly experienced medicinal and synthetic chemist with over 30 years of drug discovery experience, having held key roles at Pfizer, Janssen, and X-Chem. Currently, he serves as Senior Director at ReAx Biotechnologies and Principal at PAC MedChem Consulting. Philip has a robust background in leading project teams and collaborating with academic and biotech partners, specializing in GPCR and kinase drug discovery, tissue targeting, PROTAC design, and covalent drug discovery. He has contributed to the discovery of multiple clinical candidates, with one receiving FDA approval. Philip holds 43 issued US patents and has published 53 scientific articles in high-impact journals. Based in Baltimore, MD, he continues to drive innovation in drug discovery and medicinal chemistry.